BlackRock Fund Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.53M | Buy |
4,367
+671
| +18% | +$234K | ﹤0.01% | 3197 |
|
|
2016
Q3 | $1.49M | Buy |
3,696
+687
| +23% | +$276K | ﹤0.01% | 3202 |
|
|
2016
Q2 | $1.79M | Buy |
3,009
+2,896
| +2,563% | +$1.72M | ﹤0.01% | 3210 |
|
|
2016
Q1 | $57K | Sell |
113
-7
| -6% | -$3.53K | ﹤0.01% | 3776 |
|
|
2015
Q4 | $79K | Sell |
120
-760
| -86% | -$500K | ﹤0.01% | 3789 |
|
|
2015
Q3 | $416K | Buy |
880
+147
| +20% | +$69.5K | ﹤0.01% | 3263 |
|
|
2015
Q2 | $416K | Buy |
733
+39
| +6% | +$22.1K | ﹤0.01% | 3258 |
|
|
2015
Q1 | $5.92M | Buy |
694
+46
| +7% | +$392K | ﹤0.01% | 2749 |
|
|
2014
Q4 | $5.7M | Buy |
648
+608
| +1,520% | +$5.35M | ﹤0.01% | 2801 |
|
|
2014
Q3 | $187K | Sell |
40
-3
| -7% | -$14K | ﹤0.01% | 3496 |
|
|
2014
Q2 | $307K | Sell |
43
-342
| -89% | -$2.44M | ﹤0.01% | 3333 |
|
|
2014
Q1 | $2.07M | Buy |
+385
| New | +$2.07M | ﹤0.01% | 3136 |
|